Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer

PURPOSE: To compare palbociclib + letrozole and palbociclib + fulvestrant with chemotherapy agents in postmenopausal women with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) advanced/metastatic breast cancer (ABC/MBC) who had no prior systemic treatment fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Florence R., Varu, Abhishek, Mitra, Debanjali, Cameron, Chris, Iyer, Shrividya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645434/
https://www.ncbi.nlm.nih.gov/pubmed/28752187
http://dx.doi.org/10.1007/s10549-017-4404-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645434/
https://www.ncbi.nlm.nih.gov/pubmed/28752187
http://dx.doi.org/10.1007/s10549-017-4404-4

Ejemplares similares